Benzinga··PrnewswireAnixa Biosciences Secures Mexican Patent for Breast Cancer Vaccine Through 2040
Anixa Biosciences secures Mexican patent for breast cancer vaccine extending protection through 2040, supporting Phase 2 trial advancement.
ANIXPhase 2 clinical trialintellectual property